A multiplicative assumption would have merit in our testing against HLA-DRB1 shared epitope and PTPN22, if ACPA-positive RA were a homogeneous set of causes, rather than the kind of heterogeneity of causation that we have shown gives rise to additivity between risk factors. Here, HLA-DRB1 is linked to rheumatoid arthritis.